About: Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1995 (uk) article scientifique publié en 1995 (fr) im Juni 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1995 (ast) scientific article published on 01 June 1995 (en)
publication date	wds:Q72240687-8708A923-B3EA-4240-B5F7-C3B33B3B6AA7
publication date	1995-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72240687-7A8299B1-314B-4114-8360-2280AC24BB4B
language of work or name	English
author name string	wds:Q72240687-260F43B8-5D4F-41DC-B85F-75690F44B0DF wds:Q72240687-3371674F-D889-4A6C-8EF0-5F3262A25DFB wds:Q72240687-475C86AF-F593-4D17-B7DB-0453FA535C19 wds:Q72240687-5A91A547-76B0-4503-A4C1-F33D9FCC4D6E wds:Q72240687-80DD5457-96DA-4FA3-9DEF-9ED96759BF89 wds:Q72240687-AFC9BE9D-D377-47A7-A7F3-C2270A49C6A4 wds:Q72240687-E44DC776-5CCA-467A-AC34-86BBE47F5E9E wds:Q72240687-EC911D5C-005D-4CB5-9910-382D133437DF
author name string	V E Reuter C Cordon-Cardo A S Sarkis G Netto H W Herr H I Scher D F Bajorin P K Schultz
rdfs:label	Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC (en) Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC (nl)
skos:prefLabel	Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC (en) Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC (nl)
name	Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC (en) Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC (nl)
author	wds:Q72240687-63723FFE-497F-44BC-8257-C297259AA440
author	Zuo-Feng Zhang
title	wds:Q72240687-25843BB9-F0A1-491E-ABC2-53BD87A67D54
title	Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC (en)
page(s)	wds:Q72240687-09DE62C8-2C91-4D57-A576-92243D31AF13
page(s)	1384-1390
instance of	wds:Q72240687-10C44DE3-486C-4AF5-B1EC-2E9D86617D18
instance of	scholarly article
main subject	wds:Q72240687-8D852FD2-FB2E-41B7-8069-E28DC5876B8A
main subject	bladder cancer
PubMed ID	wds:Q72240687-221AFA3E-BAEF-40D4-B26A-8E6D025FA473
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7751883
PubMed ID	7751883
published in	wds:Q72240687-D1CB5913-CCBB-4216-889A-75ED172EA831
published in	Journal of Clinical Oncology
issue	wds:Q72240687-599C8470-915F-4FEB-AF86-F628408F3376
volume	wds:Q72240687-CD8E86C2-6C64-4126-B067-2CD33A53154B
issue	6
volume	13
DOI	wds:Q72240687-93A5B67A-5E6B-4F6A-806C-C9A42D36E30D
DOI	http://dx.doi.org/10.1200/JCO.1995.13.6.1384
DOI	10.1200/JCO.1995.13.6.1384
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72240687
is cites work of	P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity Molecular aspects of bladder cancer III. Prognostic markers of bladder cancer Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer Cisplatin: mode of cytotoxic action and molecular basis of resistance Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53. Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder P53 as a prognostic marker for bladder cancer: a meta-analysis and review. Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers Therapy of invasive bladder cancer Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens The natural history of bladder cancer. Implications for therapy Absence of p53 overexpression and favorable response to cisplatin-based neoadjuvant chemotherapy in urothelial carcinomas p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy New drugs and new approaches in metastatic bladder cancer Neoadjuvant chemotherapy for bladder cancer The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer. Molecular targeting and pharmacogenomics in the management of advanced bladder cancer Current therapeutic strategies for invasive and metastatic bladder cancer. Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids New and promising strategies in the management of bladder cancer. Chemotherapy for Invasive Bladder Cancer: Five Simple Rules Learned Over 30 Years The role of systemic chemotherapy in the management of muscle-invasive bladder cancer Individualized management of advanced bladder cancer: Where do we stand? Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy Correlation between expressions of Cyclin-D1, EGFR and p53 with chemoradiation response in patients of locally advanced oral squamous cell carcinoma A critical analysis of the use of p53 as a marker for management of bladder cancer Clinical significance of nuclear p53 protein accumulation in bladder cancer Laser-emission imaging of nuclear biomarkers for high-contrast cancer screening and immunodiagnosis Molecular Predictors of Complete Response Following Neoadjuvant Chemotherapy in Urothelial Carcinoma of the Bladder and Upper Tracts Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy. Environment and bladder cancer: molecular analysis by interaction networks Profile of p53 expression in bladder and oral tumours. Effects of in vitro manipulations of p53 on the behaviour of established human tumour cell lines Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy Two different forms of p53 localized differently within cells of urogenital tumours Recent advances in treatment of advanced urothelial carcinoma Negative p53/positive p21 immunostaining is a predictor of favorable response to chemotherapy in patients with locally advanced bladder cancer. Targeted therapies in the management of metastatic bladder cancer Treatment of locally advanced and metastatic bladder cancer Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software